JAPAN CS ELITE FASTPACK, 225ML - Product Usage: its related accessory components are intended for...

FDA Device Recall #Z-0902-2020 — Class II — October 21, 2019

Recall Summary

Recall Number Z-0902-2020
Classification Class II — Moderate risk
Date Initiated October 21, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Haemonetics Corporation
Location Braintree, MA
Product Type Devices
Quantity 8114

Product Description

JAPAN CS ELITE FASTPACK, 225ML - Product Usage: its related accessory components are intended for use to recover blood shed during or subsequent to an operation or as a result of trauma, processing the blood by a centrifugation and washing procedure, and pumping this processed red cell product to either a bag for gravity reinfusion into the patient or to the arterial line of an extracorporeal circuit for reinfusion into the patient.

Reason for Recall

Potential to develop leaks at the inner core of Cell Saver¿ 5/5+ and Cell Saver¿ Elite¿/Elite¿ +125ml and 225ml bowl sets. Which could result in fluid being trapped inside the bowl core, causing a long empty device error message with the possibility of incomplete washing.

Distribution Pattern

Worldwide distribution - US Nationwide distribution in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY, and countries of NZ, AU, IN, PK, PH, HK, VN, MY, ID, SG, CN, AT, DE, FR, GB, IT, CH.

Lot / Code Information

Catalog number/FG Item Number: CSE-FP-225V-JA 1. Specific Lots with Bowl Cracks (1249 Distributed) FP Lot numbers: 1118017-0219057190124H10119084; 1118017-1118031181226H11118019; 1118017-1118031181226H11118063; 1118017-1118032181226H11118063; 1118017-1118081190124H10119084; 1118017-1118082190124H10119002; 1118017-1118082190124H20119002; 1118017-1118083190124H20119084 2. Missing instructions to check for cracks in IFU All products/lost manufactured between October 2014 and October 2019.

Other Recalls from Haemonetics Corporation

Recall # Classification Product Date
Z-1310-2022 Class II TEG 5000 Functional Fibrinogen Reagent, Item No... Apr 26, 2022
Z-1298-2022 Class II Product Name: TEG5000 Analyzer (07-022, 07-033)... Apr 19, 2022
Z-1617-2020 Class II TEG Manager software versions used in conjuncti... Feb 19, 2020
Z-0890-2020 Class II CS5/5+ Fastpacks, 225 mL, 20¿ Res Autotransfusi... Oct 21, 2019
Z-0900-2020 Class II JAPAN DISP SET, 261J, 205J, HAR - Product Usage... Oct 21, 2019

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.